Showing results (321-330 of 334) with videos related to
Sort By:
Pageof 34
Journal of the American College of Cardiology|September 1, 2024
Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of HypertensionAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.Lancet (London, England)|October 19, 2024
Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trialAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.International Journal of Stroke : Official Journal of the International Stroke Society|January 7, 2022
Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progressCraig S Anderson, Anthony Rodgers, H Asita de Silva, et al.Implementation Science : IS|November 11, 2015
Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme, David Peiris, Simon R Thompson, et al.Diabetologia|July 6, 2021
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose controlJohanne Tremblay, Mounsif Haloui, Redha Attaoua, et al.Cardiology Clinics|November 26, 2016
Innovative Approaches to Hypertension Control in Low- and Middle-Income CountriesRajesh Vedanthan, Antonio Bernabe-Ortiz, Omarys I Herasme, et al.Diabetes Care|April 22, 2018
Gaps in Guidelines for the Management of Diabetes in Low- and Middle-Income Versus High-Income Countries-A Systematic ReviewMayowa O Owolabi, Joseph O Yaria, Meena Daivadanam, et al.Plos One|April 9, 2019
The role of context in implementation research for non-communicable diseases: Answering the 'how-to' dilemmaMeena Daivadanam, Maia Ingram, Kristi Sidney Annerstedt, et al.Global Heart|November 3, 2025
Long-Term Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for the Treatment of HypertensionAbdul Salam, H Asita de Silva, Dike Ojji, et al.Journal of the American Heart Association|August 24, 2022
Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of HypertensionSonali R Gnanenthiran, Claudio Borghi, Dylan Burger, et al.Pageof 34